Invitation: EClinCloud Invited to Attend the 2022 Clinical Data Management Annual Conference and Share Foundations for More Reliable Clinical Endpoint Assessment

Source: EClinCloud. Author: EClinCloud.

The 2022 Clinical Data Management Annual Conference will be held on November 17–18 in an online format, under the theme "DHT and Clinical Data Management." Invited international and domestic industry experts will address key topics—including discussions on direct data capture technologies and compliance, development standards and applications of clinical outcome assessment (COA), and using information technology to improve the efficiency and quality of data management—to explore the challenges, opportunities, and response strategies brought by technological transformation in the digital era.
Session 2: Development Standards and Applications of Clinical Outcome Assessment (COA)
Presentation Time: Thursday, November 17, 14:00–14:30
Presentation Topic: Foundations for More Reliable Clinical Endpoint Assessment - Scale Management and Rater Training

Over 16 years of experience in technology applications for the clinical research industry;
An innovative and inspiring leader, and a pioneer in promoting and implementing eCOA, EDC, CTMS, and other technology solutions in clinical trial research in China;
Previously served as Asia-Pacific head for several international technology companies, leading rapid regional business growth;
An entrepreneur driven by academia and science, deeply committed to shaping new models for future clinical trials.

EClinCloud is a technology company dedicated to clinical R&D. It provides an integrated, interoperable all-in-one cloud platform for clinical trials—including technology products such as CTMS, eTMF, EDC, RTSM, eCOA, and eConsent and solutions such as scale management, linguistic validation, rater training, and data quality analysis—along with clinical trial endpoint assessment technologies across therapeutic areas (including oncology, central nervous system, ophthalmology, and others). By combining cutting-edge technology with life data to build a globally leading, patient-centric SaaS cloud platform supporting clinical evidence, it helps pharmaceutical companies and research institutions in China and abroad improve R&D efficiency and accelerate the market launch of drugs/devices, benefiting countless patients.



